Curaleaf Holdings (CURLF) Deferred Taxes (2019 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Deferred Taxes of $81.6 million for Q4 2024, up 81.69% year-over-year from $44.9 million in Q1 2024, and up 821.1% quarter-over-quarter from -$11.3 million in Q3 2024.
Curaleaf Holdings (CURLF) Deferred Taxes (2019 - 2024) Analysis & Trends
Curaleaf Holdings' Deferred Taxes history runs 6 years deep, the most recent figure standing at $81.6 million for Q4 2024.
- In Q4 2024, Deferred Taxes rose 81.69% year-over-year to $81.6 million; the TTM figure through Dec 2024 stood at $109.0 million (up 82.42% YoY), while the FY2025 annual figure was $34.1 million, down 37.44% from the prior year.
- Deferred Taxes for Q4 2024 stood at $81.6 million, up from -$11.3 million in the prior quarter.
- The five-year high for Deferred Taxes was $81.6 million in Q4 2024, with the low at -$12.6 million in Q3 2022.
- The 5-year median for Deferred Taxes is -$1.7 million (2021), against an average of $7.8 million.
- The sharpest annual moves came in 2020 and 2022: Deferred Taxes sank 306.84% in 2020, then jumped 482.57% in 2022.
- Curaleaf Holdings' Deferred Taxes stood at -$6.0 million in 2020, then sank by 45.12% to -$8.8 million in 2021, then surged by 482.57% to $33.6 million in 2022, then jumped by 33.7% to $44.9 million in 2023, then surged by 81.69% to $81.6 million in 2024.
- Business Quant data shows CURLF's Deferred Taxes at $81.6 million in Q4 2024, -$11.3 million in Q3 2024, and $44.9 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Curaleaf Holdings | 2.51 Bn | 2.42 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 81.60 Mn |
| Sep 30, 2024 | -11.32 Mn |
| Dec 31, 2023 | 44.91 Mn |
| Sep 30, 2023 | -6.20 Mn |
| Dec 31, 2022 | 33.59 Mn |
| Sep 30, 2022 | -12.55 Mn |
| Jun 30, 2022 | -5.92 Mn |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | -8.78 Mn |
| Sep 30, 2021 | -10.07 Mn |
| Jun 30, 2021 | 11.69 Mn |
| Mar 31, 2021 | -3.44 Mn |
| Dec 31, 2020 | -6.05 Mn |
| Sep 30, 2020 | 11.27 Mn |
| Jun 30, 2020 | 4.57 Mn |
| Mar 31, 2020 | 1.94 Mn |
| Dec 31, 2019 | 2.93 Mn |